Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Immunoglobulin G Deficiency

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Michael A Kaliner, MD  more...
 
Updated: Oct 26, 2015
 

Background

Immunodeficiency diseases are commonly classified into disorders that affect one or more of the 4 major limbs of the immune system. These limbs are (1) B cells, ie, humoral immunity; (2) T cells, ie, cell-mediated immunity; (3) phagocytes; and (4) complement.

B-cell immunity is mediated by the immunoglobulins and is commonly referred to as humoral immunity. Humoral immunity is differentiated from T-cell immunity, which is commonly referred to as cellular immunity, and from phagocytic cell immune function. Immunoglobulins, which are protein molecules that contain antibody activity, are produced by the terminal cells of B-cell differentiation known as plasma cells. Immunoglobulins have important roles in humoral immunity, and they consist of 5 major classes or isotypes: immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), immunoglobulin D (IgD), and immunoglobulin E (IgE). The most abundant class of immunoglobulins in the blood is IgG (73%), which has a molecular weight of 150 kd. IgG is present in plasma and external secretions and is expressed on the B-cell membrane.

Immunoglobulin G deficiency. Schematic representat Immunoglobulin G deficiency. Schematic representation of an immunoglobulin G molecule. CH indicates constant region of heavy chain; CL, constant region of light chain; VH, variable region of heavy chain; and VL, variable region of light chain.

IgG is further subdivided into 4 subclasses: IgG1, IgG2, IgG3, and IgG4. Fortunately, for ease of recall, the serum concentrations of the subclasses directly correlate with their numerical nomenclature, such that IgG1 is found in greater concentrations than IgG2, and so forth.

Immunoglobulin G deficiency. Human immunoglobulin Immunoglobulin G deficiency. Human immunoglobulin G subclasses.

In 1952, Bruton described classic X-linked agammaglobulinemia due to B-cell deficiency in an 8-year-old boy. The child presented with frequent pyogenic infections, repeated episodes of sepsis with the same serotypes of pneumococcus, and multiple episodes of mumps, yet he had no antibodies against these pathogens. Serum protein electrophoresis had just become available, and it revealed that the g fraction was missing from the child’s blood. Subsequently, patients were described who had detectable lymphoid tissue and B-cells but had decreased IgG levels and/or lacked specific antibodies. These conditions are now recognized as fitting the categories of hyper-IgM syndromes and common variable immunodeficiency (CVID). A new subset of the latter was recently characterized by reduced C1 esterase inhibitor levels.[1]

In the early 1960s, following the discovery of the IgG subclasses, certain associations were also recognized between individual subclass deficiencies, decreased ability to respond to certain types of antigens (ie, bacterial polysaccharides), and recurrent infection. IgG deficiencies may occur as isolated deficiencies (eg, selective IgG deficiency) or in association with deficiencies of other immunoglobulin types. Moreover, even if the total IgG concentration is normal, deficiencies of one or more individual IgG subclasses, significant decreases in specific IgG antibodies, or both may be observed.

For information on deficiencies of other immunoglobulin types, see the Medscape Reference articles IgA Deficiency, IgD Deficiency, and IgM Deficiency.

Next

Pathophysiology

B and T cells are responsible for specific immunity, otherwise known as adaptive immunity. Adaptive immune responses require rearrangement of the genes responsible for the specific recognition structures, ie, immunoglobulins for humoral immunity and T-cell receptors for cellular immunity. Inability to form these recognition structures or blocks in the differentiation and development of either of these cell types results in primary immune deficiency. Abnormal production of these cells may also be observed in clinical states in which production of abnormal cell types is pathologically excessive (eg, lymphoproliferative diseases such as lymphoma and leukemia) or in immunodeficiency disorders in which production is aberrantly low.[2] Humoral immune defects can also result from excessive loss of antibody proteins (eg, protein-losing enteropathy, certain forms of nephritis), even though the B-cell mass may be normal in those conditions.

IgG is well distributed in intravascular and extravascular spaces and is important in the secondary antibody responses (immune memory). It plays an important role in host defense against infection. IgG protects tissues from bacteria, viruses, and toxins. Different subclasses of IgG neutralize bacterial toxins, activate complement, and enhance phagocytosis by opsonization.[3]

Importantly, note that a low IgG level, with normal IgA and IgM levels, does not necessarily equate with antibody deficiency. The evaluation of specific antibody responses is essential for the diagnosis and for appropriate treatment.

For ease of discussion, IgG deficiencies may be divided into 2 categories. The first is selective IgG deficiency, which consists of an isolated deficiency of IgG with normal levels of IgA, IgM, IgD, and IgE. The second is a deficiency of IgG accompanied by inadequate levels of other immunoglobulin isotypes. This may occur in various conditions, including X-linked agammaglobulinemia (X-LA), common variable immunodeficiency (CVID), and hyper-IgM syndromes.

These disorders occur in persons of any age or sex. Selective immunoglobulin deficiencies were previously referred to as late-onset agammaglobulinemia, and now they are classified under the general designation of antibody deficiency. Both pediatric and adult populations may be affected by specific or selective antibody deficiencies, CVID, or both. See Common variable immunodeficiency for more details.

IgA deficiency is the most common immune deficiency. Although some "normal" blood donors may be found to be deficient in IgA, approximately 20% of patients who lack IgA are also deficient in IgG2 and IgG4. These individuals appear to have a greater risk of infection than patients with isolated IgA deficiency.

Previous
Next

Epidemiology

Frequency

Although the frequency of isolated IgG deficiency is not known with certainty, deficiencies in specific IgG antibody or IgG subclass is probably more common and occurs in families with common variable immunodeficiency (CVID). Some reports indicate that the prevalence of IgG deficiency may be 1 case per 10,000 persons.

Mortality/Morbidity

Early diagnosis and treatment of IgG deficiency is essential to prevent and control both morbidity and mortality.

IgG subclass levels are highly variable, even within individuals at different points in time. Their development in early childhood varies from subclass to subclass; IgG 2 is the slowest to reach adult values. Additional deficiencies may become apparent because of defective switching between different IgG subclasses.

Age

Both children and adults are affected. Children younger than 24 months cannot make much IgG2; hence, measuring the IgG2 subclass concentration before this age is not meaningful.

The most common subclass deficiency in early childhood is IgG2 deficiency; in adults, IgG1 and IgG3 deficiencies predominate. IgG1 accounts for a higher proportion of the total IgG in children as compared to adults. Although children rapidly attain adult levels of IgG1 and IgG3, the development of IgG2 and IgG4 is slower. In some children, maturation of the full range of IgG subclasses may be delayed until the teenage years. Note the figure below.

Immunoglobulin G deficiency. Changes in serum immu Immunoglobulin G deficiency. Changes in serum immunoglobulin G concentrations during infancy and childhood.

One recent study found an isolated IgG3 subclass deficiency was the most common IgG subclass deficiency in Thai children. IgG3 subclass deficiency, either isolated or combined with other IgG subclass deficiency, was found in 85.5% of 55 children, most of whom were first evaluated for recurrent sinusitis.[4]

Previous
 
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, Rutgers New Jersey Medical School; Visiting Professor, Rutgers University School of Public Affairs and Administration

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, New York Academy of Medicine, American Academy of Dermatology, American College of Physicians, Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Robert Y Lin, MD Professor, Department of Medicine, New York Medical College; Chief, Allergy and Immunology, and Director of Utilization Review, Department Medicine, New York Downtown Hospital

Robert Y Lin, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, New York Allergy & Asthma Society

Disclosure: Nothing to disclose.

Janet Vafaie, MD Private Practice

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Michael R Simon, MD, MA Clinical Professor Emeritus, Departments of Internal Medicine and Pediatrics, Wayne State University School of Medicine; Professor, Department of Internal Medicine, Oakland University William Beaumont University School of Medicine; Adjunct Staff, Division of Allergy and Immunology, Department of Internal Medicine, William Beaumont Hospital

Michael R Simon, MD, MA is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology, Michigan State Medical Society, Michigan Allergy and Asthma Society, American College of Physicians, American Federation for Medical Research, Royal College of Physicians and Surgeons of Canada, Society for Experimental Biology and Medicine

Disclosure: Received ownership interest from Secretory IgA, Inc. for management position; Received ownership interest from siRNAx, Inc. for management position.

Chief Editor

Michael A Kaliner, MD Clinical Professor of Medicine, George Washington University School of Medicine; Medical Director, Institute for Asthma and Allergy

Michael A Kaliner, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American College of Allergy, Asthma and Immunology, American Society for Clinical Investigation, American Thoracic Society, Association of American Physicians

Disclosure: Nothing to disclose.

Additional Contributors

Melvin Berger, MD, PhD Adjunct Professor of Pediatrics and Pathology, Case Western Reserve University; Senior Medical Director, Clinical Research and Development, CSL Behring, LLC

Melvin Berger, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Clinical Investigation, Clinical Immunology Society

Disclosure: Received salary from CSL Behring for employment; Received ownership interest from CSL Behring for employment; Received consulting fee from America''s Health insurance plans for subject matter expert for clinical immunization safety assessment network acvtivity of cdc.

References
  1. Melamed IR, Heffron M, McGee S, Ulltate Sanz L, Testori A. A new subset of common variable immune deficiency characterized by reduced C1 esterase inhibitor levels. Ann Allergy Asthma Immunol. 2015 Jul. 115 (1):83-4. [Medline].

  2. Yong PF, Chee R, Grimbacher B. Hypogammaglobulinaemia. Immunol Allergy Clin North Am. 2008 Nov. 28(4):691-713. [Medline].

  3. Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Treatment. 17th ed. Whitehouse Station, NJ: Merck & Co; 2004. Vol 12:

  4. Visitsunthorn N, Hengcrawit W, Jirapongsananuruk O, Luangwedchakam V. Immunoglobulin G (IgG) subclass deficiency in Thai children. Asian Pac J Allergy Immunol. 2011 Dec. 29(4):332-7. [Medline].

  5. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009 Mar 27. [Medline]. [Full Text].

  6. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007 Sep. 99(3):281-3. [Medline].

  7. Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol. 2007 Nov. 99(5):462-4. [Medline].

  8. Chouksey AK, Berger M. Assessment of protein antibody response in patients with suspected immune deficiency. Ann Allergy Asthma Immunol. 2008 Feb. 100(2):166-8. [Medline].

  9. Aucouturier P, Lacombe C, Bremard C, et al. Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections. Clin Immunol Immunopathol. 1989 Apr. 51(1):22-37. [Medline].

  10. Sikora AG, Lee KC. Otolaryngologic Manifestations of Immunodeficiency. Otolaryngologic Clinics of North America. Philadelphia, Pa: WB Saunders; 2003. Vol 36: 647.

  11. Heiner DC, Myers A, Beck CS. Deficiency of IgG4: a disorder associated with frequent infections and bronchiectasis that may be familial. Clin Rev Allergy. 1983 Jun. 1(2):259-66. [Medline].

  12. Jain A, Atkinson TP, Lipsky PE, et al. Defects of T-cell effector function and post-thymic maturation in X- linked hyper-IgM syndrome. J Clin Invest. 1999 Apr. 103(8):1151-8. [Medline].

  13. Khvatova AV, Skriabina OA, Kargina IB, et al. [Immunodiagnosis of retinoblastoma]. Vestn Oftalmol. 1992 May-Jun. 108(3):34-6. [Medline].

  14. Caksen H, Oner AF, Arslan S, et al. Immunoglobulin subgroups in children with febrile seizures. Pediatr Int. 2001 Feb. 43(1):58-60. [Medline].

  15. Ojuawo A, Milla PJ, Lindley KJ. Serum immunoglobulin and immunoglobulin G subclasses in children with allergic colitis. West Afr J Med. 1998 Jul-Sep. 17(3):206-9. [Medline].

  16. Ojuawo A, St Louis D, Lindley KJ. Non-infective colitis in infancy: evidence in favour of minor immunodeficiency in its pathogenesis. Arch Dis Child. 1997 Apr. 76(4):345-8. [Medline].

  17. Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy?. Curr Allergy Asthma Rep. 2002 Sep. 2(5):356-60. [Medline].

  18. Stiehm ER. The four most common pediatric immunodeficiencies. J Immunotoxicol. 2008 Apr. 5(2):227-34. [Medline].

  19. Svensson T, Höglund M, Cherif H. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia. Scand J Infect Dis. 2013 Jul. 45(7):537-42. [Medline].

  20. Freeman JA, Crassini KR, Best OG, Forsyth CJ, Mackinlay NJ, Han P, et al. Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Jan. 54(1):99-104. [Medline].

  21. Adkinson NF. B Cell Immunodeficiency. Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER. Middleton's Allergy: Principles and Practice. 6th ed. St. Louis, Mo: Mosby; 2004. 1062-7.

  22. Ladwig PM, Barnidge DR, Snyder MR, Katzmann JA, Murray DL. Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry. Clin Chem. 2014 Aug. 60(8):1080-8. [Medline].

  23. Nobre FA, Gonzalez IG, Simão RM, de Moraes Pinto MI, Costa-Carvalho BT. Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study. BMC Immunol. 2014 Jun 21. 15:26. [Medline]. [Full Text].

  24. Abdou NI, Greenwell CA, Mehta R, Narra M, Hester JD, Halsey JF. Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults. Int Arch Allergy Immunol. 2009 Feb 12. 149(3):267-274. [Medline].

  25. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases. 5th ed. New York, NY: Churchhill Livingston; 2000. Vol 1: 59-61.

  26. Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol. 2006 Jan. 26(1):65-72. [Medline].

  27. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. 2008 May. 28(2):413-37, x. [Medline].

  28. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev. 2003 Oct. 17(4):241-51. [Medline].

  29. Torgerson TR. Overview of routes of IgG administration. J Clin Immunol. 2013 Jan. 33 Suppl 2:S87-9. [Medline].

  30. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006 Apr. 117(4 Suppl):S525-53. [Medline].

  31. Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin North Am. 2008 Nov. 28(4):779-802, viii. [Medline].

  32. Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. 2006 May. 26(3):265-73. [Medline].

  33. Ho CH, Chien RN, Cheng PN, Liu JH, Liu CK, Su CS, et al. Aberrant Serum Immunoglobulin G Glycosylation in Chronic Hepatitis B Is Associated With Histological Liver Damage and Reversible by Antiviral Therapy. J Infect Dis. 2014 Jul 10. [Medline].

  34. Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012 Mar. 167(3):479-91. [Medline].

  35. Ekdahl K, Braconier JH, Svanborg C. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection. Clin Infect Dis. 1997 Sep. 25(3):654-60. [Medline].

  36. Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001 Oct 23. 98(22):12614-9. [Medline].

  37. Gleeson M, McDonald WA, Cripps AW, et al. The effect on immunity of long-term intensive training in elite swimmers. Clin Exp Immunol. 1995 Oct. 102(1):210-6. [Medline].

  38. Guneser S, Antmen B, Altintas D, Yilmaz M. The frequency of IgG subclass deficiency in children with recurrent respiratory infections. Turk J Pediatr. 1996 Apr-Jun. 38(2):161-8. [Medline].

  39. Hamilos DL, Young RM, Peter JB, et al. Hypogammaglobulinemia in asthmatic patients. Ann Allergy. 1992 Jun. 68(6):472-81. [Medline].

  40. Hoffman R. Antibody Deficiencies. Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000. 765-70.

  41. Imai K, Catalan N, Plebani A, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest. 2003 Jul. 112(1):136-42. [Medline].

  42. Inoue R, Kondo N, Kobayashi Y, et al. IgG2 deficiency associated with defects in production of interferon- gamma; comparison with common variable immunodeficiency. Scand J Immunol. 1995 Feb. 41(2):130-4. [Medline].

  43. Lacombe C, Aucouturier P, Preud'homme JL. Selective IgG1 deficiency. Clin Immunol Immunopathol. 1997 Aug. 84(2):194-201. [Medline].

  44. Lassoued K, Oksenhendler E, Lambin JP, et al. Severe neutropenia associated with IgG2 subclass deficiency and bone marrow T-lymphocyte infiltration. Am J Hematol. 1998 Mar. 57(3):241-4. [Medline].

  45. May A, Zielen S, Reimold I, et al. [Immunoglobulin subclass defects in patients with therapy refractor chronic rhinosinusitis]. HNO. 1999 Jan. 47(1):19-24. [Medline].

  46. Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000.

  47. Roifman CM, Schroeder H, Berger M, et al. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. Int Immunopharmacol. 2003 Sep. 3(9):1325-33. [Medline].

  48. Sakiyama Y, Komiyama A, Shiraki K, et al. [Intravenous immunoglobulin (GB-0998) for prophylaxis of recurrent acute otitis media and lower respiratory tract infection in infancy with IgG 2 deficiency]. Nihon Rinsho Meneki Gakkai Kaishi. 1998 Apr. 21(2):70-9. [Medline].

  49. Sandler SG, Trimble J, Mallory DM. Coexistent IgG2 and IgA deficiencies in blood donors. Transfusion. 1996 Mar. 36(3):256-8. [Medline].

  50. Sekerel BE, Saraclar Y, Sanal O, et al. IgG subclasses in children with recurrent respiratory tract infections in an allergy practice. Acta Paediatr Jpn. 1996 Apr. 38(2):124-7. [Medline].

  51. Shackelford PG, Granoff DM, Madassery JV, et al. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res. 1990 Jan. 27(1):16-21. [Medline].

  52. Shephard RJ, Rhind S, Shek PN. The impact of exercise on the immune system: NK cells, interleukins 1 and 2, and related responses. Exerc Sport Sci Rev. 1995. 23:215-41. [Medline].

  53. Smith LJ, Szymanski W, Foulston C, et al. Familial enteropathy with villous edema and immunoglobulin G2 subclass deficiency. J Pediatr. 1994 Oct. 125(4):541-8. [Medline].

  54. Snowden JA, Milford-Ward A, Reilly JT. Symptomatic IgG3 deficiency successfully treated with intravenous immunoglobulin therapy. Postgrad Med J. 1994 Dec. 70(830):924-6. [Medline].

  55. Tezcan I, Ersoy F, Sanal O, et al. IgG subclass deficiency in children with recurrent infections. Turk J Pediatr. 1991 Jul-Sep. 33(3):163-6. [Medline].

  56. Travin M, Macris NT, Block JM, Schwimmer D. Reversible common variable immunodeficiency syndrome induced by phenytoin. Arch Intern Med. 1989 Jun. 149(6):1421-2. [Medline].

  57. Tsujihata M, Satoh A, Yoshimura T, et al. Effect of myasthenic immunoglobulin G on motor end-plate morphology. J Neurol. 2003 Jan. 250:75-82. [Medline].

  58. Van Kessel DA, Horikx PE, Van Houte AJ, et al. Clinical and immunological evaluation of patients with mild IgG1 deficiency. Clin Exp Immunol. 1999 Oct. 118(1):102-7. [Medline].

 
Previous
Next
 
Immunoglobulin G deficiency. Schematic representation of an immunoglobulin G molecule. CH indicates constant region of heavy chain; CL, constant region of light chain; VH, variable region of heavy chain; and VL, variable region of light chain.
Immunoglobulin G deficiency. Human immunoglobulin G subclasses.
Immunoglobulin G deficiency. Changes in serum immunoglobulin G concentrations during infancy and childhood.
Immunoglobulin G deficiency. Schematic representation of the molecular interaction of CD40 on B cells, with CD40L on T cells involved in the switch from immunoglobulin M to immunoglobulin G.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.